Spain· ES:91222

LANREOTIDA ZENTIVA 60 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA EFG

A lanreotide product containing lanreotida, registered in Spain by Zentiva K.S.. The same ATC class is registered in 17 of our 19 countries.

ATC H01CB03

Checked against AEMPS CIMA (Spain) on August 10, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about lanreotidaAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Lanreotide is registered in 17 of 19 countries.

Countries holding a registration under ATC H01CB03 (lanreotide), each read from that country’s own register.

This record: Spain, from AEMPS CIMA (Spain)
10 of them publish a price we can compare per daily dose

Search lanreotide products by name

Lanreotide · ATC H01CB03

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of lanreotide costs, country by country.

Normalised to the WHO defined daily dose (3 mg), so markets compare like for like.

2 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Lanreotide · price per daily dose (3 mg)

USD · FX 28 Sept 2026

FR France$53.80
CH Switzerland$44.46

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

AEMPS CIMA (Spain)

Active substance: lanreotida
Manufacturer: Zentiva K.S.
Country: Spain (ES)
ATC code: H01CB03
ATC class: Lanreotide
Defined daily dose: 3 mg, P
Reimbursed: Not published by this register
Source register: AEMPS CIMA (Spain)
Last checked: August 10, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

157 interactions on record for lanreotide.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check lanreotide against other medicines How interaction checks work

Lanreotide · interactions on record

157 records

2 severe
151 moderate
4 minor

Most severe, free to view

LonafarnibA16AX20severe
PexidartinibL01EX15severe
LiraglutidA08AX02moderate
SemaglutidA08AX03moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Lanreotide in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lanreotide products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

Austria · Lanreotid Sun Pharma, Lanreotid Viatris
Belgium · Lanreotide Sun, Lanreotide Viatris
Cyprus · Somatuline Autogel
Czechia · Lanreotid Sun, Lanreotid Zentiva
Germany · Lanreotid Sun, Lanreotid Viatris
Denmark · Ipstyl Autogel, Lanreotid Amdipharm Limited
Estonia · Myrelez, Somatuline Autogel
Finland · Lanreotid Sun, Lanreotid Zentiva
France · Lanreotide L.P. Biogaran, Lanréotide Viatris Lp
United Kingdom (Northern Ireland) · Lanreotide Mylan, Lanreotide Zentiva
Greece · Lanrod, Myrelez
Hungary · Lanreotid Sun, Somatuline Autogel
Ireland · Lanreotide Sun, Lanreotide Viatris
Italy · Ipstyl, Lanrenet
Lithuania · Myrelez, Somatuline Autogel
Luxembourg · Somatuline Autogel Injectable, Somatuline Autogel Injectable120
Latvia · Myrelez, Somatuline Autogel
Netherlands · Lanreotide Sun, Mytolac
Norway · Ipstyl Autogel, Lanreotid Sun
Poland · Lanreotide Zentiva, Myrelez
Portugal · Myrelez, Somatulina Autogel
Romania · Lanreotidă Terapia, Lanreotidă Zentiva
Sweden · Lanreotid Amdipharm, Lanreotid Sun
Slovenia · Somatuline Autogel
Slovakia · Lanreotid Sun, Lanreotid Zentiva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/0c298d77-fd90-4146-858c-bdb490fcbf7d
GET /v1/drugs/0c298d77-fd90-4146-858c-bdb490fcbf7d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cpresc": "Diagnóstico Hospitalario",
  "estado": "{\"aut\":1785998041000}",
  "nregistro": "91222",
  "substance": "lanreotida"
}

API reference MCP server Plans

See everything about lanreotide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console